EMA — authorised 18 December 2020
- Marketing authorisation holder: UCB PHARMA S.A.
- Status: approved
🇪🇺 Fintepla in European Union
EMA authorised Fintepla on 18 December 2020
Marketing authorisation
Fintepla in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Fintepla approved in European Union?
Yes. EMA authorised it on 18 December 2020.
Who is the marketing authorisation holder for Fintepla in European Union?
UCB PHARMA S.A. holds the EU marketing authorisation.